You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Allogeneic Donors

Showing 1 - 25 of 3,515
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Haplo-identical Transplantation, Transplantation Trial in Paris (Evaluate the evolution of the psychic state of the donors

Not yet recruiting
  • Haplo-identical Transplantation
  • Transplantation
  • Evaluate the evolution of the psychic state of the donors (ascendants and descendants), by means of questionnaires, within the framework of haplo-identical allograft.
  • Paris, France
    Service D'hématologie Clinique et thérapie cellulaire - Hôpital
Oct 17, 2023

Allogenic Granulocyte Donation Trial run by the National Institutes of Health Clinical Center (CC) (Filgrastim, Dexamethasone)

Recruiting
  • Allogeneic Granulocyte Donation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 7, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Multiple Myeloma Trial in Hamburg (allogeneic HSCT)

Completed
  • Multiple Myeloma
  • allogeneic HSCT
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Sep 1, 2022

HPV 16+ Recurrent or Metastatic Cancer Trial (CD8 reduced peripheral blood cells taken from related donors vaccinated against

Not yet recruiting
  • HPV 16+ Recurrent or Metastatic Cancer
  • CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
  • Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
  • (no location specified)
Jun 27, 2022

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR

Active, not recruiting
  • Leukemia
  • KIR genotyping
  • HLA genotyping
  • Tampa, Florida
  • +9 more
Nov 29, 2022

Multi-Drug Resistant Organism Trial in Decatur (Allogeneic Microbiota in Glycerol (10%) (AMG))

Not yet recruiting
  • Multi-Drug Resistant Organism
  • Allogeneic Microbiota in Glycerol (10%) (AMG)
  • Decatur, Georgia
    Emory Long-Term Acute Care
Mar 20, 2023

Ischemia Reperfusion Injury Trial in Jacksonville (Allogeneic adipose derived mesenchymal stem cells)

Recruiting
  • Ischemia Reperfusion Injury
  • Allogeneic adipose derived mesenchymal stem cells
  • Jacksonville, Florida
    Mayo Clinic in Florida
Oct 7, 2021

Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

Hematological Malignancies Trial in Belgium, Netherlands (Conditioning regimen: TBI + Fludarabine, Conditioning regimen:TLI (8

Completed
Has Results
  • Hematological Malignancies
  • Conditioning regimen: TBI + Fludarabine
  • Conditioning regimen:TLI (8 Gy) + ATG
  • Leuven, Flamish Brabant, Belgium
  • +10 more
Nov 16, 2021

Hematologic Malignancies Trial in Baltimore (drug, radiation, procedure)

Recruiting
  • Hematologic Malignancies
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Radiation
  • +3 more
  • New Hyde Park, New York
    Cohen Children's Medical Center
Apr 6, 2022

Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)

Recruiting
  • Myeloid Malignancies
  • Lymphoid Malignancies
  • NK Cell enriched-DLI only
  • NK-DLI + DUK-CPG-001
  • Durham, North Carolina
    Duke University Health System
Mar 8, 2022

Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem

Active, not recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
  • Recipients
  • Donors
  • Paris, France
    Hopital Necker
Nov 19, 2021

Hematologic Diseases Trial in Palo Alto (biological, device, drug)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • +2 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Mar 25, 2022

Lymphoma Trial in Madison (drug, radiation, biological, procedure)

Completed
Has Results
  • Lymphoma
  • Fludarabine Phosphate
  • +9 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Dec 7, 2021

Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

Active, not recruiting
  • Acute Lymphoid Leukemia (ALL)
  • +5 more
  • Hyperfractionated total body irradiation
  • +9 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)

Recruiting
  • Hematological Malignancies
  • Total Body Irradiation
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 4, 2022

Sickle Cell Disease, Thalassemia, Beta, Thalassemia Trial in United States (Fludarabine, Cyclophosphamide, Tacrolimus)

Recruiting
  • Sickle Cell Disease
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Feb 17, 2023

Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte

Recruiting
  • Lymphoid Leukemia, Acute
  • +2 more
  • T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc
May 24, 2022

Healthy Trial in United States (Filgrastim)

Recruiting
  • Healthy
  • Duarte, California
  • +19 more
Mar 7, 2022

GVHD, Hematological Malignancies Trial in Belgium (Mycophenolate mofetil, Sirolimus)

Active, not recruiting
  • Graft-Versus-Host Disease
  • Hematological Malignancies
  • Antwerpen,, Antwerpen, Belgium
  • +12 more
Mar 22, 2022

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

Recruiting
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 26, 2022

Primary Immunodeficiency, PID Trial in Pittsburgh (CD3/CD19 neg allogeneic BMT)

Active, not recruiting
  • Primary Immunodeficiency
  • PID
  • CD3/CD19 neg allogeneic BMT
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of University of Pittsburgh Me
Oct 6, 2021